Literature DB >> 17921754

The many faces of psychosis in the elderly.

Jessica Broadway1, Jacobo Mintzer.   

Abstract

PURPOSE OF REVIEW: As the population ages, the number of older patients with psychosis will greatly rise. This review focuses on the etiology, biologic and clinical findings, and treatments of common causes of psychosis in the elderly. RECENT
FINDINGS: Recent studies on psychosis related to Alzheimer's disease indicate that antipsychotic drugs have equivocal efficacy in improving psychotic symptoms and may have side effects or risks that outweigh their benefits. Behavioral interventions for agitation in dementia are showing some promise. In older adults with schizophrenia, intramuscular ziprasidone was found to be effective, and evidence is emerging for the use of hormone replacement therapy. For depression with psychosis, a recent study found that the combination of an antidepressant with an antipsychotic is no more effective than an antidepressant alone.
SUMMARY: There is support for the use of antipsychotic drugs for all types of psychosis in the elderly. While the atypical antipsychotics have a 'black box warning' on risk of death in elderly patients with dementia, the typical antipsychotics carry an even higher risk of death and adverse effects. Weighing the potential risks and benefits of treatment options is essential. Please refer to your country's regulations regarding the use of antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921754     DOI: 10.1097/YCO.0b013e3282f0f09d

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  3 in total

Review 1.  Late-life psychosis: diagnosis and treatment.

Authors:  Michael M Reinhardt; Carl I Cohen
Journal:  Curr Psychiatry Rep       Date:  2015-02       Impact factor: 5.285

2.  A drug utilization study of cognition enhancers in dementia in a tertiary care hospital in mumbai.

Authors:  Karan Thakkar; Shaurya Suman; Gauri Billa
Journal:  J Clin Diagn Res       Date:  2014-05-15

3.  Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?

Authors:  Thanh Phuong Pham Nguyen; Danielle S Abraham; Dylan Thibault; Daniel Weintraub; Allison W Willis
Journal:  BMC Neurol       Date:  2021-06-24       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.